Schedule 13G ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,202,714
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-18-000142
Form type
SC 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Feb 12, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub